Literature DB >> 11242082

Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.

F Toyoshima-Morimoto1, E Taniguchi, N Shinya, A Iwamatsu, E Nishida.   

Abstract

In vertebrate cells, the nuclear entry of Cdc2-cyclin B1 (MPF) during prophase is thought to be essential for the induction and coordination of M-phase events. Phosphorylation of cyclin B1 is central to its nuclear translocation, but the kinases that are responsible remain unknown. Here we have purified a protein kinase from Xenopus M-phase extracts that phosphorylates a crucial serine residue (S147) in the middle of the nuclear export signal sequence of cyclin B1. We have identified this kinase as Plx1 (ref. 16), a Xenopus homologue of Polo-like kinase (Plk)-1. During cell-cycle progression in HeLa cells, a change in the kinase activity of endogenous Plk1 toward S147 and/or S133 correlates with a kinase activity in the cell extracts. An anti-Plk1 antibody depletes the M-phase extracts of the kinase activity toward S147 and/or S133. An anti-phospho-S147 antibody reacts specifically with cyclin B1 only during G2/M phase. A mutant cyclin B1 in which S133 and S147 are replaced by alanines remains in the cytoplasm, whereas wild-type cyclin B1 accumulates in the nucleus during prophase. Co-expression of constitutively active Plk1 stimulates nuclear entry of cyclin B1. Our results indicate that Plk1 may be involved in targeting MPF to the nucleus during prophase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242082     DOI: 10.1038/35065617

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  119 in total

1.  The fission yeast NIMA kinase Fin1p is required for spindle function and nuclear envelope integrity.

Authors:  Michael J E Krien; Robert R West; Ulrik P John; Kalli Koniaras; J Richard McIntosh; Matthew J O'Connell
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation.

Authors:  S Ura; N Masuyama; J D Graves; Y Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1.

Authors:  Marion Peter; Christian Le Peuch; Jean-Claude Labbé; April N Meyer; Daniel J Donoghue; Marcel Dorée
Journal:  EMBO Rep       Date:  2002-05-24       Impact factor: 8.807

4.  The Polo-like kinase PLKA in Aspergillus nidulans is not essential but plays important roles during vegetative growth and development.

Authors:  Klarita Mogilevsky; Amandeep Glory; Catherine Bachewich
Journal:  Eukaryot Cell       Date:  2011-12-02

5.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 6.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

7.  Controlled damage in thick specimens by multiphoton excitation.

Authors:  James A Galbraith; Mark Terasaki
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

8.  Plk phosphorylation regulates the microtubule-stabilizing protein TCTP.

Authors:  Frederic R Yarm
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Role of Plk2 (Snk) in mouse development and cell proliferation.

Authors:  Sheng Ma; Jean Charron; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.